Parnax Lab Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "120.00",
    "chg": 0.7,
    "chgp": "0.59%",
    "dir": 1,
    "prev_price": "119.30",
    "mcapval": "137.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE383L01019",
    "curr_date": "Mar 18",
    "curr_time": "",
    "bse_nse_vol": "610 ",
    "exc_status": "Active",
    "traded_date": "Mar 18, 2026",
    "traded_date_str": "2026 03 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3895835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParnaxLabLtd_mojoScore_3895835.png",
        "date": "2026-03-17 08:07:33",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 16 March 2026. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite the company’s strong long-term returns."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-3886769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParnaxLabLtd_mojoScore_3886769.png",
        "date": "2026-03-12 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-by-marketsmojo-3863127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParnaxLabLtd_mojoScore_3863127.png",
        "date": "2026-03-01 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Parnax Lab Ltd Upgraded to Hold as Technicals Improve and Valuation Remains Attractive",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-hold-as-technicals-improve-and-valuation-remains-attractive-3836672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParnaxLabLtd_mojoScore_3836672.png",
        "date": "2026-02-13 08:04:27",
        "description": "Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, and financial trends. The upgrade, effective from 12 February 2026, comes amid a positive shift in market sentiment and operational performance, signalling a cautious but optimistic outlook for the pharmaceutical company."
      },
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-technical-weakness-and-underperformance-3827984",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParnaxLabLtd_mojoScore_3827984.png",
        "date": "2026-02-09 08:04:04",
        "description": "Parnax Lab Ltd has seen its investment rating downgraded from Hold to Sell as of 6 February 2026, driven primarily by a deterioration in technical indicators despite some positive financial metrics. The company’s overall Mojo Score has declined to 34.0, reflecting a cautious stance amid mixed signals across quality, valuation, financial trends, and technicals."
      },
      {
        "title": "When is the next results date for Parnax Lab Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-parnax-lab-ltd-3825097",
        "imagepath": "",
        "date": "2026-02-06 23:17:24",
        "description": "The next results date for Parnax Lab Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Parnax Lab Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-hold-by-marketsmojo-amid-technical-and-financial-improvements-3815603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParnaxLabLtd_mojoScore_3815603.png",
        "date": "2026-02-02 08:05:59",
        "description": "Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 1 February 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering challenges in long-term fundamentals and recent market underperformance."
      },
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3804428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ParnaxLabLtd_mojoScore_3804428.png",
        "date": "2026-01-26 08:05:10",
        "description": "Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 23 January 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quarterly performance. The company’s current Mojo Score stands at 34.0, with a Sell grade, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Parnax Lab Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-valuation-3801010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ParnaxLabLtd_mojoScore_3801010.png",
        "date": "2026-01-23 08:01:21",
        "description": "Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold as of 22 January 2026, reflecting a notable improvement in its technical outlook and valuation metrics. Despite recent underperformance relative to the broader market, the company’s financial trends and quality parameters have shown signs of stabilisation, prompting a reassessment of its investment potential."
      }
    ],
    "total": 261,
    "sid": "286243",
    "stock_news_url": "https://www.marketsmojo.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Financial Results For The Quarter Ended December 31 2025.",
      "datetime": "13-Feb-2026",
      "details": "Financial Results for the Quarter Ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended December 31 2025.",
      "datetime": "13-Feb-2026",
      "details": "Financial Results for the Quarter Ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "13-Feb-2026",
      "details": "Outcome of Board Meeting for Considered and Approved the Standalone & Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parnax Lab Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-03-17 08:07:33

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 16 March 2026. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite the company’s strong long-term returns.

Read full news article

Parnax Lab Ltd is Rated Hold

2026-03-12 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Parnax Lab Ltd is Rated Hold by MarketsMOJO

2026-03-01 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Parnax Lab Ltd Upgraded to Hold as Technicals Improve and Valuation Remains Attractive

2026-02-13 08:04:27

Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, and financial trends. The upgrade, effective from 12 February 2026, comes amid a positive shift in market sentiment and operational performance, signalling a cautious but optimistic outlook for the pharmaceutical company.

Read full news article

Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Underperformance

2026-02-09 08:04:04

Parnax Lab Ltd has seen its investment rating downgraded from Hold to Sell as of 6 February 2026, driven primarily by a deterioration in technical indicators despite some positive financial metrics. The company’s overall Mojo Score has declined to 34.0, reflecting a cautious stance amid mixed signals across quality, valuation, financial trends, and technicals.

Read full news article

When is the next results date for Parnax Lab Ltd?

2026-02-06 23:17:24

The next results date for Parnax Lab Ltd is scheduled for 13 February 2026....

Read full news article

Parnax Lab Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements

2026-02-02 08:05:59

Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 1 February 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering challenges in long-term fundamentals and recent market underperformance.

Read full news article

Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-01-26 08:05:10

Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 23 January 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quarterly performance. The company’s current Mojo Score stands at 34.0, with a Sell grade, signalling caution for investors amid a challenging market backdrop.

Read full news article

Parnax Lab Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation

2026-01-23 08:01:21

Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold as of 22 January 2026, reflecting a notable improvement in its technical outlook and valuation metrics. Despite recent underperformance relative to the broader market, the company’s financial trends and quality parameters have shown signs of stabilisation, prompting a reassessment of its investment potential.

Read full news article

View All News